We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVC
2376
DELISTED
Invacare Corporation
IVC
| $423K | ﹤0.01% |
98,425
+15,758
| +19% | +$139K |
|
|
CBIO
2377
Crescent Biopharma
CBIO
$610M
| $422K | ﹤0.01% |
446
+144
| +48% | +$173K |
|
|
CATC
2378
DELISTED
CAMBRIDGE BANCORP
CATC
| $420K | ﹤0.01% |
5,040
+1,685
| +50% | +$143K |
|
|
CVON
2379
DELISTED
ConvergeOne Holdings, Inc. Class A Common Stock
CVON
| $420K | ﹤0.01% |
33,947
+12,334
| +57% | +$136K |
|
2380
Solid Biosciences
SLDB
$857M
| $419K | ﹤0.01% |
1,043
+382
| +58% | +$180K |
|
2381
West Bancorporation
WTBA
$483M
| $419K | ﹤0.01% |
21,927
+6,655
| +44% | +$141K |
|
|
OXFD
2382
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $419K | ﹤0.01% |
32,758
+11,022
| +51% | +$167K |
|
|
LTHM
2383
DELISTED
Livent Corporation
LTHM
| $418K | ﹤0.01% |
+30,295
| New | +$495K |
|
2384
Rocket Pharmaceuticals
RCKT
$387M
| $417K | ﹤0.01% |
28,122
+9,036
| +47% | +$150K |
|
|
NXEO
2385
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $416K | ﹤0.01% |
48,446
+14,752
| +44% | +$149K |
|
2386
WillScot Mobile Mini Holdings
WSC
$4.67B
| $414K | ﹤0.01% |
43,899
+16,276
| +59% | +$231K |
|
2387
Allient
ALNT
$1.89B
| $413K | ﹤0.01% |
13,865
+4,320
| +45% | +$133K |
|
|
OMN
2388
DELISTED
OMNOVA Solutions Inc.
OMN
| $413K | ﹤0.01% |
56,397
+18,484
| +49% | +$149K |
|
2389
A10 Networks
ATEN
$1.99B
| $410K | ﹤0.01% |
65,727
+21,521
| +49% | +$130K |
|
2390
Select Water Solutions
WTTR
$2.87B
| $407K | ﹤0.01% |
64,423
+19,280
| +43% | +$191K |
|
2391
BRC Group Holdings
RILY
$292M
| $406K | ﹤0.01% |
28,581
+8,730
| +44% | +$160K |
|
|
SEI
2392
Solaris Energy Infrastructure
SEI
$3.49B
| $406K | ﹤0.01% |
33,621
+11,686
| +53% | +$166K |
|
|
RVI
2393
DELISTED
Retail Value Inc. Common Shares
RVI
| $405K | ﹤0.01% |
172,546
+98
| +0.1% | +$257 |
|
|
AXDX
2394
DELISTED
Accelerate Diagnostics
AXDX
| $404K | ﹤0.01% |
3,515
+1,096
| +45% | +$162K |
|
2395
Capital City Bank Group
CCBG
$894M
| $404K | ﹤0.01% |
17,394
+5,007
| +40% | +$121K |
|
2396
Park-Ohio Holdings
PKOH
$670M
| $403K | ﹤0.01% |
13,132
+3,973
| +43% | +$139K |
|
|
BHR
2397
Braemar Hotels & Resorts
BHR
$146M
| $402K | ﹤0.01% |
45,505
+12,333
| +37% | +$123K |
|
2398
Nordic American Tanker
NAT
$1.36B
| $399K | ﹤0.01% |
199,448
+61,188
| +44% | +$159K |
|
2399
Sterling Infrastructure
STRL
$16.4B
| $399K | ﹤0.01% |
36,645
+11,202
| +44% | +$136K |
|
|
BOJA
2400
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $399K | ﹤0.01% |
24,818
+7,657
| +45% | +$123K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.